Status:
UNKNOWN
Comparison of Pain ReliefofBupivacaineWith Dexmedetomidine and Bupivacaine Alone in TransversusAbdominisPlane Block For Postoperative Anelgesia in Patients Undergoing Abdominal Surgeries
Lead Sponsor:
Sheikh Zayed Medical College
Conditions:
Pain Relief in Post Operative Patient
Eligibility:
All Genders
18-45 years
Phase:
EARLY_PHASE1
Brief Summary
Postoperative pain related to abdominal surgeries poses significant burden on the healthcare system, in terms of increased use of different analgesics, delayed ambulation, pulmonary complications, DVT...
Detailed Description
Introduction: Pain is defined as, "an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage" by the international associat...
Eligibility Criteria
Inclusion
- Patients who will give written informed consent
- ASA I \&II
- Age between 21-45 years
- Patients undergoing abdominal surgeries
- Patients understanding VAS
Exclusion
- Patients allergic to bupivacaine or dexmeditomidine
- Complicated procedure
- History of coagulopathy
- History of chronic use of pain medications
Key Trial Info
Start Date :
October 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 10 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05244252
Start Date
October 4 2021
End Date
April 10 2022
Last Update
March 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alina Zafar
Rahim Yar Khan, Punjab Province, Pakistan, 64200